ES2163389T3 - Uso de 5-metil-1-fenil-2-(1h)-piridona en la prevencion de lesiones fibroticas. - Google Patents

Uso de 5-metil-1-fenil-2-(1h)-piridona en la prevencion de lesiones fibroticas.

Info

Publication number
ES2163389T3
ES2163389T3 ES90301607T ES90301607T ES2163389T3 ES 2163389 T3 ES2163389 T3 ES 2163389T3 ES 90301607 T ES90301607 T ES 90301607T ES 90301607 T ES90301607 T ES 90301607T ES 2163389 T3 ES2163389 T3 ES 2163389T3
Authority
ES
Spain
Prior art keywords
methyl
fibrotic
phenyl
prevention
piridone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90301607T
Other languages
English (en)
Spanish (es)
Inventor
Solmon B Margolin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2163389T3 publication Critical patent/ES2163389T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
ES90301607T 1989-02-15 1990-02-15 Uso de 5-metil-1-fenil-2-(1h)-piridona en la prevencion de lesiones fibroticas. Expired - Lifetime ES2163389T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1035436A JPH02215719A (ja) 1989-02-15 1989-02-15 線維化病変組織の修復並びに線維化病変の阻止剤

Publications (1)

Publication Number Publication Date
ES2163389T3 true ES2163389T3 (es) 2002-02-01

Family

ID=12441800

Family Applications (2)

Application Number Title Priority Date Filing Date
ES90301607T Expired - Lifetime ES2163389T3 (es) 1989-02-15 1990-02-15 Uso de 5-metil-1-fenil-2-(1h)-piridona en la prevencion de lesiones fibroticas.
ES01107235T Expired - Lifetime ES2220612T3 (es) 1989-02-15 1990-02-15 Composicion que contiene 5-metil-1-fenil-2-(1h)-piridona para reparar y prevenir lesiones fibroticas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES01107235T Expired - Lifetime ES2220612T3 (es) 1989-02-15 1990-02-15 Composicion que contiene 5-metil-1-fenil-2-(1h)-piridona para reparar y prevenir lesiones fibroticas.

Country Status (9)

Country Link
EP (3) EP0458861B1 (enExample)
JP (1) JPH02215719A (enExample)
AT (1) ATE136215T1 (enExample)
AU (1) AU633541B2 (enExample)
CA (1) CA2010017C (enExample)
DE (2) DE69033863T2 (enExample)
DK (1) DK0458861T3 (enExample)
ES (2) ES2163389T3 (enExample)
WO (1) WO1990009176A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02215719A (ja) * 1989-02-15 1990-08-28 Yamauchi Akitomo 線維化病変組織の修復並びに線維化病変の阻止剤
US5716632A (en) * 1989-11-22 1998-02-10 Margolin; Solomon B. Compositions and methods for reparation and prevention of fibrotic lesions
WO1994026249A1 (en) * 1993-05-07 1994-11-24 Margolin Solomon B Compositions and methods for reparation and prevention of fibrotic lesions
DE69632396T2 (de) * 1995-03-03 2005-05-04 Margolin, Solomon B., Dallas Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
US6492395B1 (en) 1998-09-18 2002-12-10 Mepha Ag Topical formulation of alkyl-, phenyl-pyridone
DE60234812D1 (de) 2001-01-29 2010-02-04 Shionogi & Co Arzneipräparat, das als wirkstoff 5-methyl-1-phenyl-2-(1h)-pyridon enthält
JP4542743B2 (ja) 2002-12-26 2010-09-15 Ｋｄｌ株式会社 ピリドン誘導体の溶液状医薬組成物
TW200501952A (en) * 2003-02-21 2005-01-16 Shionogi & Co Pirfenidone gel formulations
TW200418516A (en) * 2003-02-21 2004-10-01 Shionogi & Co Droplet dispersed ointment
CA2545813C (en) 2003-11-14 2011-01-04 Shanghai Genomics, Inc. The derivatives of pyridone and use thereof
CN1846699A (zh) * 2005-04-13 2006-10-18 中南大学湘雅医院 1－(取代苯基)－5－甲基－2－(1h) 吡啶酮(i)化合物用于制备抗除肾间质纤维化外其他器官纤维化或组织纤维化药物的应用
NZ591443A (en) 2005-09-22 2013-04-26 Intermune Inc Granule formation of pirfenidone and pharmaceutically acceptable excipients
CA2656017C (en) 2006-06-15 2014-02-04 Shanghai Genomics, Inc. Use of pyridone derivatives in the prevention and treatment of radiation-induced lung injuries
MX2007006347A (es) * 2007-05-29 2009-02-18 Cell Therapy And Technology S Nuevo uso de 5-metil-1-fenil-2-(1h)-piridona para el tratamiento y prevencion de cicatrices hipertroficas, y composicion conteniendo la misma.
ES2400026T3 (es) 2007-06-20 2013-04-05 Auspex Pharmaceuticals, Inc. N-arilpiridinonas sustituidas como inhibidores fibróticos
US20100099719A1 (en) * 2008-10-21 2010-04-22 Dierepharma, Inc. Composition and method for treating proteinuria
US7635707B1 (en) 2008-11-10 2009-12-22 Intermune, Inc. Pirfenidone treatment for patients with atypical liver function
US7816383B1 (en) * 2009-12-04 2010-10-19 Intermune, Inc. Methods of administering pirfenidone therapy
US8084475B2 (en) * 2009-12-04 2011-12-27 Intermune, Inc. Pirfenidone therapy and inducers of cytochrome P450
CA2824432C (en) * 2011-01-31 2021-10-19 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
AU2012225611B2 (en) 2011-03-08 2016-09-15 Auspex Pharmaceuticals, Inc. Substituted N-Aryl pyridinones
JP5872564B2 (ja) * 2011-09-14 2016-03-01 塩野義製薬株式会社 吸入用医薬組成物
WO2014012360A1 (en) 2012-07-18 2014-01-23 Sunshine Lake Pharma Co., Ltd. Nitrogenous heterocyclic derivatives and their application in drugs
US12226407B2 (en) 2012-07-24 2025-02-18 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
CA2819967C (en) 2012-08-31 2016-03-22 Intermune, Inc. Use of pirfenidone concomitantly with ciprofloxacin
AU2014366049B2 (en) * 2013-12-19 2018-04-05 Sunshine Lake Pharma Co., Ltd. Nitrogenous heterocyclic derivatives and their application in drugs
WO2016122420A1 (en) 2015-01-26 2016-08-04 Ulkar Kimya Sanayii Ve Ticaret A. S. An improved method for the synthesis and purification of pirfenidone
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
TWI745396B (zh) 2016-07-12 2021-11-11 日商鹽野義製藥股份有限公司 吸入用醫藥組成物
CN109223723B (zh) * 2017-07-11 2021-08-27 南京华威医药科技集团有限公司 吡非尼酮片剂及其制备方法和用途
MX368750B (es) 2018-08-31 2019-10-15 Cell Therapy And Tech S A De C V Composiciones farmaceuticas semisolidas de base oleosa conteniendo pirfenidona para su aplicacion en la reparacion tisular.
MX2020005775A (es) * 2020-07-13 2022-01-14 Centro De Retina Medica Y Quirurgica S C Uso farmaceutico de pirfenidona para la reduccion de fibrosis cardiaca en pacientes con cardiomiopatia y/o esteatosis cardiaca y/o covid-19.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6816241A (enExample) * 1967-12-01 1969-06-03
US3721676A (en) * 1969-11-12 1973-03-20 Merck & Co Inc Certain 3-amino-2(1h)pyridones
US3644626A (en) * 1969-11-25 1972-02-22 Merck & Co Inc Novel pyridones in compositions and methods for treating inflammation pain and fever
US3655897A (en) * 1971-01-25 1972-04-11 Merck & Co Inc Anti-inflammatory agents
CA1049411A (en) * 1972-12-18 1979-02-27 Affiliated Medical Research N-substituted pyridone and general method for preparing pyridones
US4042699A (en) * 1972-12-18 1977-08-16 Affiliated Medical Research, Inc. Method for reducing serum glucose levels
US4052509A (en) * 1972-12-18 1977-10-04 Affiliated Medical Research, Inc. Method for reducing serum uric acid levels
ZA757570B (en) * 1974-12-09 1977-07-27 Affiliated Med Res A useful n-substituted pyridone
JPH02215719A (ja) * 1989-02-15 1990-08-28 Yamauchi Akitomo 線維化病変組織の修復並びに線維化病変の阻止剤

Also Published As

Publication number Publication date
EP1138329A2 (en) 2001-10-04
WO1990009176A1 (en) 1990-08-23
EP0383591A3 (en) 1992-01-15
CA2010017A1 (en) 1990-08-15
EP0383591A2 (en) 1990-08-22
EP0458861A4 (en) 1992-07-08
ES2220612T3 (es) 2004-12-16
EP0458861A1 (en) 1991-12-04
DK0458861T3 (da) 1996-08-12
CA2010017C (en) 1995-09-05
DE69034143D1 (de) 2004-07-08
DE69033863T2 (de) 2002-06-13
JPH0552814B2 (enExample) 1993-08-06
EP1138329B8 (en) 2006-05-17
DE69034143T2 (de) 2005-06-30
AU4981290A (en) 1990-08-23
EP0458861B1 (en) 1996-04-03
AU633541B2 (en) 1993-02-04
JPH02215719A (ja) 1990-08-28
EP1138329A3 (en) 2002-04-17
ATE136215T1 (de) 1996-04-15
DE69033863D1 (de) 2002-01-03
EP1138329B1 (en) 2004-06-02
EP0383591B1 (en) 2001-11-21

Similar Documents

Publication Publication Date Title
ES2163389T3 (es) Uso de 5-metil-1-fenil-2-(1h)-piridona en la prevencion de lesiones fibroticas.
DE69118526D1 (de) Mittel zur transdermalen penetration von arzneimitteln
BR9205203A (pt) Composicao detergente,de limpeza ou de uso pessoal,e,tensoativo de gliceroglicolipidio
FI862689A7 (fi) Hapetusta kestävä kudos kuivapesussa käytettäviä aktiivisia aineita varten ja valkaisua kestäviä tuotteita.
IT1214690B (it) Cere disperdibili impiegabili come agenti di finissaggio
IT8022185A0 (it) Strumento per la cura dei piedi di notevole versatilita' di uso.
ES2095578T3 (es) Composicion para el tratamiento de mastitis y metritis.
FI911269A7 (fi) Menetelmä ja koostumus aktiivisten aineiden lisääntyneen pitoisuuden aikaansaamiseksi iholla iontoforeesin avulla
DK0429982T3 (da) Sammensætninger med kontrolleret slip samt anvendelse
ES2045008T3 (es) Procedimiento para la obtencion de preparados en combinacion antidepresivos.
AT388949B (de) Fahrbare gleisbearbeitungsmaschine fuer den weichen- und kreuzungsbereich
DK100087D0 (da) Transdermale 3-phenoxypyridin-praeparater
EP0163238A3 (en) Substituted and bridged pyridines useful as pharmaceutical agents
ES286058Y (es) Estructuracion perfeccionada en mesas de billar
BR6401935U (pt) Carrinho de chopp ambulantes
PT83547A (pt) Mesa de trabalho com prancha de trabalho e armacao
ES279005Y (es) Dispositivo perfeccionado limpiador, fregador y abrillantador
ES1002763Y (es) Adaptador porta-accesorios para mesas y muebles similares
ATA61587A (de) Hoehenverstellbares tischgestell fuer arbeits- und werktische
ES292804Y (es) Estructuracion perfeccionada para frontis de armarios y muebles similares
ES292649Y (es) Dispositivo regulador de la posicion de brazos articulados en toldos enrollables y similares.
BR9500352A (pt) Sistema de utilizaçao de troca de pallets (mesas) e utilização simultânea dos pallets (mesas) em máquinas ferramenta
IT9020835A1 (it) Utensile perfezionato per tagliare e servire porzioni di pizza e simili
BR8700264A (pt) Maquina para obtencao de peca de madeira aplicada em vassouras ou similares
TR22292A (tr) Pamuk zararhlari ile muecadele aleti

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 383591

Country of ref document: ES